Bausch Health Companies Inc. (NYSE: BHC) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Arthur Shannon -- Senior Vice President, Head of
Bausch Health Companies Inc. (BHC) Q2 2021 Earnings Call Transcript
Categories
Health Care
IPO News: What awaits Adagio Therapeutics after stock market debut?
The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The latest statistics
IPO News: Here’s everything you need to know about Healthcare Royalty’s upcoming IPO
In the first half of 2021, a record number of private companies entered stock markets in the US, marking a multifold increase
AbbVie Inc (ABBV) Q2 2021 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q2 2021 earnings call dated July 30, 2021 Corporate Participants: Liz Shea -- Vice President of Investor Relations Richard A.
Stryker Corp (SYK) Q2 2021 Earnings Call Transcript
Stryker Corp (NYSE: SYK) Q2 2021 earnings call dated Jul. 27, 2021. Corporate Participants: Kevin A. Lobo -- Chairman and Chief Executive Officer
IQVIA Holdings Inc (IQV) Q2 2021 Earnings Call Transcript
IQVIA Holdings Inc (NYSE: IQV) Q2 2021 earnings call dated Jul. 27, 2021. Corporate Participants: Nicholas Childs -- Senior Vice President of
Centene Corporation (CNC) Q2 2021 Earnings Call Transcript
Centene Corporation (NYSE: CNC) Q2 2021 earnings call dated Jul. 27, 2021. Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance &
ImmunoGen Inc. (IMGN) Q2 2021 Earnings Call Transcript
ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its second-quarter financial results for the period ended June 30, 2021. Net revenues increased 34% to $13.9
Infographic: Highlights of Gilead Sciences (GILD) Q2 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell. The revenue increased by 21%
Merck & Co., Inc. (MRK) Q2 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q2 2021 earnings call dated Jul. 29, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert
Infographic: Highlights of Merck & Co. (MRK)Q2 2021 earnings report
Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021. Worldwide sales edged up 22% year-over-year
Pfizer (PFE) expects to manufacture up to 3 billion doses of COVID vaccine by end of this year
Shares of Pfizer Inc. (NYSE: PFE) were up 3.5% on Wednesday after the pharma giant reported second quarter 2021 revenue and earnings
Pfizer, Inc. (PFE) Q2 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo -- Senior Vice President, Chief Investor Relations Officer
WCG Clinical IPO: Here’s what you should know before investing in the stock
Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business expansion to
Aphria Inc (APHA) Q1 2021 Earnings Call Transcript
Aphria Inc (NYSE: APHA) Q1 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin D.
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2021 Earnings Call Transcript
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Kevin C. Mannix -- Senior Vice President,
Humana Inc. (HUM) Q2 2021 Earnings Call Transcript
Humana Inc. (NYSE: HUM) Q2 2021 earnings call dated Jul. 28, 2021 Corporate Participants: Amy Smith -- Vice President of Investor Relations Bruce D.
Pfizer Inc. (PFE) Q2 2021 Earnings Call
Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo — Senior Vice President, Chief Investor Relations Officer Albert
Infographic: How Pfizer (PFE) performed in Q2 2021
Pfizer Inc. (NYSE: PFE) reported second quarter 2021 earnings results today. Total revenue increased 92% year-over-year to $19 billion. GAAP net income
Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q2 2021 earnings call dated Jul. 27, 2021 Corporate Participants: Lauren Tengler -- Investor Relations Michael F. Mahoney -- Chairman and